Discounted Cash Flow
Avanos Medical, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $1.6b | $39.8m | $159.7m | 2.5% | $0.85 |
| 2017 | $611.6m (-61.6%) | $79.3m (99.2%) | $101.0m (-36.8%) | 13.0% (418.7%) | $1.69 (98.8%) |
| 2018 | $652.3m (6.7%) | $57.5m (-27.5%) | $-194.7m (-292.8%) | 8.8% (-32.0%) | $1.22 (-27.8%) |
| 2019 | $697.6m (6.9%) | $-45.9m (-179.8%) | $-125.1m (35.7%) | -6.6% (-174.6%) | $-0.96 (-178.7%) |
| 2020 | $714.8m (2.5%) | $-27.2m (40.7%) | $-6.5m (94.8%) | -3.8% (42.2%) | $-0.57 (40.6%) |
| 2021 | $744.6m (4.2%) | $5.2m (119.1%) | $87.3m (1443.1%) | 0.7% (118.4%) | $0.11 (119.3%) |
| 2022 | $820.0m (10.1%) | $50.5m (871.2%) | $90.9m (4.1%) | 6.2% (781.9%) | $1.08 (881.8%) |
| 2023 | $673.3m (-17.9%) | $-61.8m (-222.4%) | $14.6m (-83.9%) | -9.2% (-249.0%) | $-1.32 (-222.2%) |
| 2024 | $687.8m (2.2%) | $-392.1m (-534.5%) | $82.9m (467.8%) | -57.0% (-521.1%) | $-8.53 (-546.2%) |
| 2025 | $701.2m (1.9%) | $-72.9m (81.4%) | $43.1m (-48.0%) | -10.4% (81.8%) | $-1.57 (81.6%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.